These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21057241)

  • 21. [Effects and complications of neuroleptics (110 hospitalizations in neurology)].
    Destee A; Montagne B; Rousseaux M; Petit H; Warot P
    Lille Med; 1980; 25(6):291-5. PubMed ID: 6105602
    [No Abstract]   [Full Text] [Related]  

  • 22. Decreased extrapyramidal side effects and polypsichopharmacy in family practice outpatients.
    Holt RJ
    Bol Asoc Med P R; 1983 Aug; 75(8):351-2. PubMed ID: 6139115
    [No Abstract]   [Full Text] [Related]  

  • 23. [Recent research trends in diagnosis, treatment, and prevention of drug-induced extrapyramidal symptoms seen in psychiatric patients].
    Inada T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Oct; 16(5):181-5. PubMed ID: 8962437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [First application of tablet form bromperidol in man with particular consideration of tolerance].
    Pöldinger W; Bures E
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():26-9. PubMed ID: 35474
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute extrapyramidal syndromes in neuroleptic-treated elders: a pilot study.
    Ganzini L; Heintz R; Hoffman WF; Keepers GA; Casey DE
    J Geriatr Psychiatry Neurol; 1991; 4(4):222-5. PubMed ID: 1686396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.
    Moritz S; Krausz M; Gottwalz E; Andresen B
    Compr Psychiatry; 2000; 41(4):284-8. PubMed ID: 10929797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsychotic drug side effects: their relationship to dose.
    Kane JM
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):16-21. PubMed ID: 2859276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical assessment of extrapyramidal signs in nursing home patients given antipsychotic medication.
    Avorn J; Monane M; Everitt DE; Beers MH; Fields D
    Arch Intern Med; 1994 May; 154(10):1113-7. PubMed ID: 7910451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG; Kopala LC; Rabinowitz J
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism].
    Reggiani K; Vandel P; Haffen E; Sechter D; Bizouard P; Vandel S
    Encephale; 2000; 26(1):62-7. PubMed ID: 10875063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nursing and extrapyramidal symptoms: a response to Clarke.
    Mutsatsa S; Rinomhota S
    J Psychiatr Ment Health Nurs; 2002 Apr; 9(2):221-5. PubMed ID: 11966993
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug monitoring in psychiatry].
    Helmchen H; Hippius H; Müller-Oerlinghausen B; Rüther E
    Nervenarzt; 1985 Jan; 56(1):12-8. PubMed ID: 2858063
    [No Abstract]   [Full Text] [Related]  

  • 33. [Incidence of rigor during treatment with flupentixol decanoate in comparison to risperidone].
    Scherer J; Dobmeier P; Kuhn K; Schmaus W
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S167-9. PubMed ID: 15570542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
    Casey DE
    Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safe use of high dose neuroleptics in a psychiatric intensive care unit.
    Goldney RD; Spence ND; Bowes JA
    Aust N Z J Psychiatry; 1986 Sep; 20(3):370-5. PubMed ID: 2879529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic drug doses in a schizophrenia inpatient unit.
    Galletly CA
    Aust N Z J Psychiatry; 1992 Dec; 26(4):574-6. PubMed ID: 1362051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment with high doses of neuroleptics in the acute phase of mental diseases].
    Dencker SJ
    Acta Psiquiatr Psicol Am Lat; 1979 Jun; 25(2):157-60. PubMed ID: 44806
    [No Abstract]   [Full Text] [Related]  

  • 39. Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?
    Nosè M; Tansella M; Thornicroft G; Schene A; Becker T; Veronese A; Leese M; Koeter M; Angermeyer M; Barbui C
    Int Clin Psychopharmacol; 2008 Sep; 23(5):287-90. PubMed ID: 18703938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.